Isotretinoin Gap

Isotretinoin, the active ingredient in Isotretinoin Gap, is a retinoid presented as an oral capsule for oral use. It treats severe nodular acne and acne vulgaris that have not responded to other therapies.

GNH USA supplies Isotretinoin Gap as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin is a retinoid used in the management of severe acne conditions.

- Severe nodular acne: reduces lesion count and promotes clearance of nodules. - Acne vulgaris refractory to other therapies: decreases sebum production and inflammation, leading to clinical improvement. - Acne conglobata: helps achieve reduction of extensive inflammatory lesions.

Isotretinoin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry skin and mucous membranes: dryness of skin, lips (cheilitis), and eyes. - Elevated liver enzymes: mild transaminase increases detectable on routine labs. - Hypertriglyceridemia: rise in blood triglyceride levels. - Photosensitivity: increased susceptibility to sunburn. - Musculoskeletal discomfort: joint or muscle aches. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Teratogenicity: severe birth defects if exposure occurs during pregnancy. - Depression or suicidal ideation: mood changes requiring immediate evaluation. - Inflammatory bowel disease: new onset or exacerbation of ulcerative colitis or Crohn's disease. - Severe liver injury: marked elevation of hepatic enzymes or hepatitis. - Pancreatitis: acute inflammation of the pancreas. - Pseudotumor cerebri: increased intracranial pressure presenting with headache and visual changes.

Before initiating therapy, clinicians should assess several safety considerations.

- Pregnancy contraindication: drug is category X and must not be used during pregnancy. - Teratogenic risk: ensure effective contraception before, during, and for at least one month after discontinuation. - Baseline labs: monitor liver function tests and lipid profile prior to and during treatment. - Psychiatric monitoring: watch for mood changes, depression, or suicidal thoughts. - Avoid vitamin A supplementation: concurrent use may increase toxicity. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Isotretinoin can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Tetracyclines: increased risk of intracranial hypertension. - Vitamin A supplements: additive toxicity leading to severe hypervitaminosis A. - Systemic corticosteroids: may diminish isotretinoin efficacy.

Moderate Interactions (Monitor Closely): - Other oral retinoids (e.g., acitretin): cumulative retinoid toxicity. - Anticonvulsants (e.g., phenobarbital, carbamazepine): enzyme induction may lower isotretinoin levels. - Oral contraceptives: may alter hepatic enzyme activity, affecting drug metabolism.